SWDCF Quote, Financials, Valuation and Earnings

Cloetta AB has a net margin of 3.11% compared to Swedencare AB's net margin of 8.68%. Swedencare AB's return on equity of 0.84% beat Cloetta AB's return on equity of 12.96%.

Swedencare AB has a consensus price target of --, signalling downside risk potential of --. On the other hand Cloetta AB has an analysts' consensus of -- which suggests that it could fall by --. Given that Swedencare AB has higher upside potential than Cloetta AB, analysts believe Swedencare AB is more attractive than Cloetta AB.

Swedencare AB has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Cloetta AB has a beta of -0.322, suggesting its less volatile than the S&P 500 by 132.198%.

Swedencare AB has a quarterly dividend of $0.02 per share corresponding to a yield of 0.64%. Cloetta AB offers a yield of 3.11% to investors and pays a quarterly dividend of $0.11 per share. Swedencare AB pays 40.15% of its earnings as a dividend. Cloetta AB pays out 65.88% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Swedencare AB quarterly revenues are $74.9M, which are smaller than Cloetta AB quarterly revenues of $228.7M. Swedencare AB's net income of $2.3M is lower than Cloetta AB's net income of $19.9M. Notably, Swedencare AB's price-to-earnings ratio is 101.57x while Cloetta AB's PE ratio is 14.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Swedencare AB is 2.34x versus 1.19x for Cloetta AB. Usually stocks with elevated PS ratios are considered overvalued.

Essity AB has a net margin of 3.11% compared to Swedencare AB's net margin of 9.7%. Swedencare AB's return on equity of 0.84% beat Essity AB's return on equity of 14.71%.

Swedencare AB has a consensus price target of --, signalling downside risk potential of --. On the other hand Essity AB has an analysts' consensus of -- which suggests that it could fall by --. Given that Swedencare AB has higher upside potential than Essity AB, analysts believe Swedencare AB is more attractive than Essity AB.

Swedencare AB has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Essity AB has a beta of 0.112, suggesting its less volatile than the S&P 500 by 88.834%.

Swedencare AB has a quarterly dividend of $0.02 per share corresponding to a yield of 0.64%. Essity AB offers a yield of 2.99% to investors and pays a quarterly dividend of $0.82 per share. Swedencare AB pays 40.15% of its earnings as a dividend. Essity AB pays out 47.79% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Swedencare AB quarterly revenues are $74.9M, which are smaller than Essity AB quarterly revenues of $3.6B. Swedencare AB's net income of $2.3M is lower than Essity AB's net income of $352.8M. Notably, Swedencare AB's price-to-earnings ratio is 101.57x while Essity AB's PE ratio is 15.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Swedencare AB is 2.34x versus 1.36x for Essity AB. Usually stocks with elevated PS ratios are considered overvalued.

Oatly Group AB has a net margin of 3.11% compared to Swedencare AB's net margin of -29.36%. Swedencare AB's return on equity of 0.84% beat Oatly Group AB's return on equity of -195.09%.

Swedencare AB has a consensus price target of --, signalling downside risk potential of --. On the other hand Oatly Group AB has an analysts' consensus of $20.17 which suggests that it could grow by 78.36%. Given that Oatly Group AB has higher upside potential than Swedencare AB, analysts believe Oatly Group AB is more attractive than Swedencare AB.

Swedencare AB has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Oatly Group AB has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Swedencare AB has a quarterly dividend of $0.02 per share corresponding to a yield of 0.64%. Oatly Group AB offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Swedencare AB pays 40.15% of its earnings as a dividend. Oatly Group AB pays out -- of its earnings as a dividend. Swedencare AB's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Swedencare AB quarterly revenues are $74.9M, which are smaller than Oatly Group AB quarterly revenues of $222.2M. Swedencare AB's net income of $2.3M is higher than Oatly Group AB's net income of -$65.2M. Notably, Swedencare AB's price-to-earnings ratio is 101.57x while Oatly Group AB's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Swedencare AB is 2.34x versus 0.40x for Oatly Group AB. Usually stocks with elevated PS ratios are considered overvalued.

Zinzino AB has a net margin of 3.11% compared to Swedencare AB's net margin of 12.04%. Swedencare AB's return on equity of 0.84% beat Zinzino AB's return on equity of 54.49%.

Swedencare AB has a consensus price target of --, signalling downside risk potential of --. On the other hand Zinzino AB has an analysts' consensus of -- which suggests that it could fall by --. Given that Swedencare AB has higher upside potential than Zinzino AB, analysts believe Swedencare AB is more attractive than Zinzino AB.

Swedencare AB has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Zinzino AB has a beta of 0.761, suggesting its less volatile than the S&P 500 by 23.868%.

Swedencare AB has a quarterly dividend of $0.02 per share corresponding to a yield of 0.64%. Zinzino AB offers a yield of 2.39% to investors and pays a quarterly dividend of $0.41 per share. Swedencare AB pays 40.15% of its earnings as a dividend. Zinzino AB pays out 80.84% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Swedencare AB quarterly revenues are $74.9M, which are smaller than Zinzino AB quarterly revenues of $78.1M. Swedencare AB's net income of $2.3M is lower than Zinzino AB's net income of $9.4M. Notably, Swedencare AB's price-to-earnings ratio is 101.57x while Zinzino AB's PE ratio is 26.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Swedencare AB is 2.34x versus 2.29x for Zinzino AB. Usually stocks with elevated PS ratios are considered overvalued.